Skip to content

NTHI NTHI Total Equity

Total Equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$20.07B+15.4%
Pfizer logo
PfizerPFE
$90.1B-0.3%
Merck & Co. logo
Merck & Co.MRK
$45.88B-5.1%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$14.22M-32.1%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$415.56M+89.1%
Nuvation Bio logo
Nuvation BioNUVB
$319.56M-23.8%

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's total equity?
NTHI (NTHI) reported total equity of -$13.23M in Q1 2026.
How has NTHI's total equity changed year-over-year?
NTHI's total equity decreased by 37.5% year-over-year, from -$9.62M to -$13.23M.
What is the long-term trend for NTHI's total equity?
Over 2 years (2023 to 2025), NTHI's total equity has grown at a 11.9% compound annual growth rate (CAGR), from -$13.99M to -$17.51M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.